PIM
IMVT icon

Platinum Investment Management’s Immunovant IMVT Stock Holding History

Platinum Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57M Sell
144,671
-37,103
-20% -$1.13M 1.37% 20
2026
Q1 		$4.52M Hold
181,774
– – 1.14% 30
2025
Q4 		$4.62M Sell
181,774
-13,953
-7% -$311K 1.07% 33
2025
Q3 		$3.16M Hold
195,727
– – 0.2% 51
2025
Q2 		$3.13M Buy
195,727
+38,738
+25% +$586K 0.21% 46
2025
Q1 		$2.68M Sell
156,989
-45,334
-22% -$948K 0.16% 44
2024
Q4 		$5.01M Buy
202,323
+10,081
+5% +$286K 0.29% 35
2024
Q3 		$5.48M Hold
192,242
– – 0.25% 37
2024
Q2 		$5.08M Buy
192,242
+1,586
+0.8% +$45.1K 0.21% 37
2024
Q1 		$6.16M Sell
190,656
-38,109
-17% -$1.39M 0.25% 37
2023
Q4 		$9.64M Buy
228,765
+2,826
+1% +$104K 0.39% 40
2023
Q3 		$8.67M Sell
225,939
-102,903
-31% -$2.33M 0.34% 37
2023
Q2 		$6.24M Sell
328,842
-18,128
-5% -$338K 0.22% 51
2023
Q1 		$5.38M Sell
346,970
-64,327
-16% -$1.12M 0.19% 54
2022
Q4 		$7.3M Sell
411,297
-247,778
-38% -$3.12M 0.28% 44
2022
Q3 		$3.68M Sell
659,075
-118,515
-15% -$579K 0.15% 55
2022
Q2 		$3.03M Buy
777,590
+90,930
+13% +$393K 0.11% 66
2022
Q1 		$3.78M Buy
686,660
+70,760
+11% +$441K 0.12% 63
2021
Q4 		$5.25M Buy
615,900
+60,835
+11% +$502K 0.15% 61
2021
Q3 		$4.82M Buy
+555,065
New +$5.01M 0.14% 66

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Platinum Investment Management's IMVT Position: Q2 2026 in Review

Platinum Investment Management reduced its Immunovant (IMVT) stake by 20% in Q2 2026, selling an estimated $1.13M and leaving 144,671 shares worth $5.57M. The position accounts for 1.37% of the portfolio, ranked #20.

Platinum Investment Management first reported a position in IMVT in Q3 2021 and has held it in 20 quarters since. The position peaked at $9.64M in Q4 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Platinum Investment Management held 144,671 shares of Immunovant worth $5.57M as of Q2 2026.
  • Platinum Investment Management sold 37,103 Immunovant shares in Q2 2026, an estimated $1.13M.
  • Immunovant made up 1.37% of Platinum Investment Management's portfolio in Q2 2026, its #20 holding.
  • Platinum Investment Management first reported a position in Immunovant in Q3 2021 and has held it in 20 quarters since.
  • Platinum Investment Management's Immunovant position peaked at $9.64M in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.